4th Global Meeting on Implementing New and Under-utilized Vaccines, 22-25 June 2010
The global meeting on Implementing New and Under-Utilized Vaccines (NUVI) serves as an annual forum for individuals working at global, regional and country levels, both in the private and public sectors, to discuss issues pertaining to the introduction of new and under-utilized vaccines.
The fourth Annual Global NUVI meeting was organized by WHO/HQ and held in Montreux, Switzerland from 23-25 June 2010 with over 140 participants including representatives from WHO, UNICEF (HQ, Regional and Country Offices), Ministries of Health, National Advisory Committees, academia, NGOs, industry, and partner agencies including AMP, The Bill and Melinda Gates Foundation, CDC, GAVI, JHSPH, JSI, LSHTM and PATH.
The main objectives of this year's meeting were the following: To review progress in the implementation of the Global Plan of Action for New and Under-Utilized Vaccines Implementation (NUVI PoA), and to discuss key issues related to this plan among immunization partners, regions and country representatives.
Particular consideration and review were given to the following topics:
- Progress in the Global NUVI PoA with a focus on Hib, pneumococcal and rotavirus vaccines and follow-up on recommendations from the 2009 workshops.
- The availability and functionality of the cold chain and logistics as a key component of the process of new vaccine introduction.
- Financing for new vaccines introduction, including an update from the GAVI Secretariat on implications of recent Board decisions.
- The updated WHO vaccine donations policy.
- The roll-out of Meningitis A vaccine in West Africa.
- Updates on pneumococcal and rotavirus vaccines.
- New vaccine introduction in lower middle income countries.
- Financing and planning for immunization.
- Introduction of more than one new vaccine at a time.
- The impact of new vaccine introduction on immunization and health systems.
- Vaccines of regional importance: typhoid and cholera.
- Integrated approaches to vaccine-preventable disease control.
- Data quality and surveillance.
Priorities to be undertaken by the different partner institutions in the coming year were identified, the main ones being to achieve sustainable financial support, strengthen immunization systems including supporting cold chain and logistics preparedness, make vaccines more affordable, improve surveillance data quality, and support integrated approaches to disease prevention and control.
- Introductory session
- Workgroup 1. Pneumococcal and rotavirus vaccines, including surveillance and cost-effectiveness issues
- Workgroup 2. New vaccine introduction in lower middle income countries
- Workgroup 3. Planning and financing for immunization
- Workgroup 4. Introduction of more than one new vaccine at a time
- Workgroup 5. Impact of new vaccine introduction on immunization and health systems
- Workgroup 6. Vaccines of regional importance: typhoid and cholera
- Workgroup 7. Integrated approaches to vaccine-preventable disease control
- Workgroup 8. Data quality and surveillance - Is this as good as it gets? Can information on immunization be improved?
- Market Place Session
- Panel Discussion